AC IMMUNE SA (ACIU) Forecast, Price Target & Analyst Ratings

Name: AC IMMUNE SA (ACIU) Analyst Consensus Rating
Brand: AC IMMUNE SA
Rating: 9 (10 reviews)

NASDAQ:ACIU • CH0329023102

2.56 USD

-0.14 (-5.19%)

Last: Mar 30, 2026, 04:30 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AC IMMUNE SA (ACIU).

Consensus Price Target

Price Target

$9.18

+ 258.59% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Apr 23, 2026
Period: Q1 / 2026
EPS Estimate: -CHF0.18
Revenue Estimate: 413.202K

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

88.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$9.18

Upside

+ 258.59%

From current price of $2.56 to mean target of $9.18, Based on 10 analyst forecasts

Low

$7.07

Median

$8.67

High

$12.60

Price Target Revisions

1 Month

0.00%

3 Months

0.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for ACIU. The average price target is 9.18 USD. This implies a price increase of 258.59% is expected in the next year compared to the current price of 2.56.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

88.00%

ACIU was analyzed by 10 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about ACIU.

In the previous month the buy percentage consensus was at a similar level.

ACIU was analyzed by 10 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2026-03-16	BTIG	Reiterate	Buy -> Buy
2025-11-04	BTIG	Reiterate	Buy -> Buy
2025-09-08	BTIG	Reiterate	Buy -> Buy
2025-05-01	HC Wainwright & Co.	Maintains	Buy -> Buy
2025-04-03	HC Wainwright & Co.	Reiterate	Buy -> Buy
2025-03-14	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-11-15	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-11-06	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-09-18	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-05-31	BTIG	Initiate	Buy
2024-03-15	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-11-13	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-08-07	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-06-28	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-05-01	HC Wainwright & Co.	Reiterate	Buy
2023-04-19	HC Wainwright & Co.	Reiterate	Buy
2023-03-17	HC Wainwright & Co.	Reiterate	Buy
2022-07-11	SVB Leerink	Maintains	Outperform
2021-12-20	SVB Leerink	Maintains	Outperform
2021-03-24	HC Wainwright & Co.	Maintains	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: Apr 23, 2026
Period: Q1 / 2026
EPS Estimate: -CHF0.18
Revenue Estimate: 413.202K
Revenue Q2Q: -58.26%
EPS Q2Q: 6.56%
Number of Analysts: 3

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

N/A

EPS (3 Months)

N/A

Next Earnings Summary

ACIU is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 413.20K USD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	14.801M 279.51%	27.309M 84.51%	3.573M -86.92%	26.275M 635.38%	87.386M 232.58%	58.783M -32.73%	86.512M 47.17%	140.95M 62.93%
EBITDA YoY % growth	-51.409M 24.88%	-50.216M 2.32%	-66.36M -32.15%	-61.302M 7.62%	13.872M 122.63%	-80.613M -681.12%	-73.861M 8.38%	N/A
EBIT YoY % growth	-53.624M 24.26%	-52.378M 2.32%	-68.863M -31.47%	-64.312M 6.61%	15.654M 124.34%	-7.994M -151.07%	42.861M 636.16%	164.13M 282.94%
Operating Margin	-362.30%	-191.80%	-1,927.32%	-244.76%	17.91%	-13.60%	49.54%	116.45%
EPS YoY % growth	-0.64 24.71%	-0.52 18.75%	-0.69 -32.69%	-0.62 10.66%	0.15 125.12%	0.26 65.70%	0.03 -87.83%	0.53 1,592.81%

All data in CHF

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26
EPS Q2Q % growth	-0.18 6.56%	-0.18 15.46%	-0.18 -10.96%	-0.18 -36.57%
Revenue Q2Q % growth	413.202K -58.26%	46.313M 3,446.17%	413.202K -56.00%	413.202K 22.25%
EBITDA Q2Q % growth	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-18.73M 3.30%	-18.73M 3.39%	-18.73M -19.31%	-18.73M -30.02%

All data in CHF

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

33.36%

EPS Next 5 Year

22.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

137.09%

Revenue Next 5 Year

99.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

-3.78%

EBIT Next 5 Year

-0.60%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AC IMMUNE SA / ACIU Forecast FAQ

What do analysts expect the price target to be for AC IMMUNE SA (ACIU)?

10 analysts have analysed ACIU and the average price target is 9.18 USD. This implies a price increase of 258.59% is expected in the next year compared to the current price of 2.56.

Can you provide the upcoming earnings date for AC IMMUNE SA?

AC IMMUNE SA (ACIU) will report earnings on 2026-04-23.

What are the consensus estimates for AC IMMUNE SA (ACIU) next earnings?

The consensus EPS estimate for the next earnings of AC IMMUNE SA (ACIU) is -0.18 USD and the consensus revenue estimate is 413.20K USD.

What is the expected long term growth rate for ACIU stock?

The expected long term growth rate for AC IMMUNE SA (ACIU) is 137.09%.

Analyst forecast overview

Forecast Snapshot